Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Transcenta's Osemitamab (TST001) Targeting Claudin18.2 Granted Orphan Drug Designation for Treatment of Pancreatic Cancer 2023-03-29 14:00
Antengene Announces First Patient Dosed with Claudin 18.2 Antibody-Drug Conjugate ATG-022 for the Treatment of Patients with Advanced or Metastatic Solid Tumors in Australia 2023-03-29 08:30
Innovent Announces 2022 Annual Results and Business Updates 2023-03-29 08:00
Verbal Beginnings partners with The Clinician to launch a Patient Reported Outcomes Program for Children with Autism Spectrum Disorder 2023-03-29 02:32
Antengene Announces Results for Full Year 2022 with Updates Highlighting a Sales Revenue Reaching 5.6 Times Year-Over-Year and Accelerated Global Innovation 2023-03-28 21:40
BIMINI HEALTH TECH ACQUIRES EXCLUSIVE LICENSE TO ACELLULAR DERMAL MATRIX PRODUCT PORTFOLIO 2023-03-28 21:20
New Study Reveals Clinical Instability Predicts Psychiatric Hospitalization 2023-03-28 21:00
Pulnovo Medical Announces 3-Year Follow-up Results from PADN-5 at THT 2023, The Medical Device Maker Breaks New Ground in Heart Failure Treatment 2023-03-28 20:30
WuXi Biologics Congratulates Amicus Therapeutics on European Commission Approval for Pombiliti™ in Patients with Late-Onset Pompe Disease 2023-03-28 20:11
Sirnaomics Announces 2022 Annual Results 2023-03-28 19:26
Seegene declares to share Syndromic PCR technologies to prevent future pandemics 2023-03-28 19:00
Grey Wolf Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Study of GRWD5769 in Patients with Advanced Solid Tumours 2023-03-28 19:00
BD and A*STAR collaborate to Advance Ultra-High Dimensional Analysis in Flow Cytometry for Immunology Research 2023-03-28 14:12
Tavneos® (avacopan) included in updated EULAR recommendations for the management of AAV 2023-03-28 13:00
HaemaLogiX to present final data from anti-KMA CAR-T preclinical studies at AACR 2023-03-28 09:43
BioDuro-Sundia Announces Formation of Scientific Advisory Board 2023-03-28 08:30
Boan Biotech Announces 2022 Financial Results 2023-03-27 23:15
YS Biopharma's PIKA Recombinant COVID-19 Vaccine Demonstrates Superior Antibody Neutralization Responses Compared to Inactivated COVID-19 Vaccine in Phase II Head-to-Head Clinical Study 2023-03-27 18:00
Noul Co. Ltd - The RIGHT Foundation Commences Research and Development for Supporting Malaria Control 2023-03-27 17:34
Everest Medicines Receives Full Upfront Payment from Gilead for Trodelvy-Related Transaction, Boosting Pro Forma Cash Reserves 2023-03-27 08:15
1 122 123 124 125 126 533